McCowen KC, et al. Stress-induced hyperglycemia. Crit Care Clin. 2001;17(1):107–24.
Article
CAS
PubMed
Google Scholar
Dungan KM, et al. Stress hyperglycaemia. Lancet. 2009;373(9677):1798–807.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mizock BA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med. 1995;98(1):75–84.
Article
CAS
PubMed
Google Scholar
McGuinness OP, et al. Impact of acute epinephrine removal on hepatic glucose metabolism during stress hormone infusion. Metabolism. 1999;48(7):910–4.
Article
CAS
PubMed
Google Scholar
Robinson LE, van Soeren MH. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clin Issues. 2004;15(1):45–62.
Article
PubMed
Google Scholar
Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78(12):1471–8.
Article
PubMed
Google Scholar
Finney SJ, et al. Glucose control and mortality in critically ill patients. JAMA. 2003;290(15):2041–7.
Article
CAS
PubMed
Google Scholar
Bagshaw SM, et al. Early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med. 2009;37(2):463–70.
Article
CAS
PubMed
Google Scholar
Egi M, et al. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105(2):244–52.
Article
CAS
PubMed
Google Scholar
Dandona P, et al. Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. Am J Cardiol. 2007;99(4a):15b–26b.
Article
CAS
PubMed
Google Scholar
Esposito K, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106(16):2067–72.
Article
CAS
Google Scholar
Ingels C, et al. Glucose homeostasis, nutrition and infections during critical illness. Clin Microbiol Infect. 2018;24(1):10–5.
Article
CAS
PubMed
Google Scholar
der Voort PH, et al. Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients. Clin Endocrinol (Oxf). 2006;64(2):141–5.
Article
Google Scholar
Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock. Crit Care Med. 2017;45(3):486–552.
Article
PubMed
Google Scholar
Van den Berghe G, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–67.
Article
PubMed
Google Scholar
Van den Berghe G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449–61.
Article
PubMed
Google Scholar
De La Rosa C, et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care. 2008;12(5):R120.
Article
Google Scholar
Brunkhorst FM, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125–39.
Article
CAS
PubMed
Google Scholar
Arabi YM, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36(12):3190–7.
Article
CAS
PubMed
Google Scholar
Vlasselaers D, et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet. 2009;373(9663):547–56.
Article
CAS
PubMed
Google Scholar
Finfer S, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97.
Article
PubMed
Google Scholar
Preiser JC, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the glucontrol study. Intensive Care Med. 2009;35(10):1738–48.
Article
CAS
PubMed
Google Scholar
Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest. 2010;137(3):544–51.
Article
CAS
PubMed
Google Scholar
Lena D, et al. Glycemic control in the intensive care unit and during the postoperative period. Anesthesiology. 2011;114(2):438–44.
Article
PubMed
Google Scholar
Jacobi J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40(12):3251–76.
Article
PubMed
Google Scholar
Moghissi ES, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–31.
Article
PubMed
PubMed Central
Google Scholar
Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414(6865):799–806.
Article
CAS
PubMed
Google Scholar
Sun Q, et al. New insights into insulin: the anti-inflammatory effect and its clinical relevance. World J Diabetes. 2014;5(2):89–96.
Article
PubMed
PubMed Central
Google Scholar
Chaudhuri A, et al. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation. 2004;109(7):849–54.
Article
CAS
PubMed
Google Scholar
Langouche L, et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest. 2005;115(8):2277–86.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mesotten D, et al. Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J Clin Endocrinol Metab. 2002;87(12):5516–23.
Article
CAS
PubMed
Google Scholar
Price HI, et al. Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: a systematic review. BMJ Open. 2015;5(3):e006341.
Article
PubMed
PubMed Central
Google Scholar
Gamble JM, et al. Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study. Lancet Diabetes Endocrinol. 2017;5(1):43–52.
Article
CAS
PubMed
Google Scholar
Van den Berghe G, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31(2):359–66.
Article
PubMed
Google Scholar
The World Medical Association. Declaration of Helsinki—ethical principles for medical research involving human subjects. 64th WMA General Assembly, Fortaleza, Brazil. 2013.
Von Elm E, et al. The Strengthening the Reporting of Observational Studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–9.
Article
Google Scholar
Rood E, et al. Use of a computerized guideline for glucose regulation in the intensive care unit improved both guideline adherence and glucose regulation. J Am Med Inform Assoc. 2005;12(2):172–80.
Article
PubMed
PubMed Central
Google Scholar
Siegelaar SE, et al. Mean glucose during ICU admission is related to mortality by a U-shaped curve in surgical and medical patients: a retrospective cohort study. Crit Care. 2010;14(6):R224.
Article
PubMed
PubMed Central
Google Scholar
Hermanides J, et al. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38(3):838–42.
Article
CAS
PubMed
Google Scholar
Sechterberger MK, et al. The effect of diabetes mellitus on the association between measures of glycaemic control and ICU mortality: a retrospective cohort study. Crit Care. 2013;17(2):R52.
Article
PubMed
PubMed Central
Google Scholar
Committee for Medicinal Products for Human Use. Guideline on adjustment for baseline covariates in clinical trials. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2015/03/WC500184923.pdf (2015). Accessed 1 Mar 2018.
Gamble JM, et al. Insulin use and increased risk of mortality in type 2 diabetes: a cohort study. Diabetes Obes Metab. 2010;12(1):47–53.
Article
CAS
PubMed
Google Scholar
Currie CJ, et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010;375(9713):481–9.
Article
CAS
PubMed
Google Scholar
Mellbin LG, et al. Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the diabetes mellitus insulin–glucose infusion in acute myocardial infarction (DIGAMI) 2 study. Diabetologia. 2011;54(6):1308–17.
Article
CAS
PubMed
Google Scholar
Bowker SL, et al. Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure. Diabetologia. 2010;53(8):1631–7.
Article
CAS
PubMed
Google Scholar
Currie CJ, et al. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 2009;52(9):1766–77.
Article
CAS
PubMed
Google Scholar
Currie CJ, Johnson JA. The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern. Diabetes Obes Metab. 2012;14(1):1–4.
Article
CAS
PubMed
Google Scholar
Wang CC, et al. Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways. Diabetes. 2003;52(10):2562–9.
Article
CAS
PubMed
Google Scholar
Mesotten D, Van den Berghe G. Mechanisms of insulin-induced alterations in metabolism during critical illness. Nestle Nutr Workshop Ser Clin Perform Programme. 2004;9:69–75.
Article
CAS
PubMed
Google Scholar
Gao F, et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation. 2002;105(12):1497–502.
Article
CAS
PubMed
Google Scholar
Van der Voort PH, et al. Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients. Clin Endocrinol. 2006;64(2):141–5.
Article
Google Scholar
Casaer MP, et al. Role of disease and macronutrient dose in the randomized controlled EPaNIC trial: a post hoc analysis. Am J Respir Crit Care Med. 2013;187(3):247–55.
Article
PubMed
Google Scholar
Vanhorebeek I, et al. Effect of early supplemental parenteral nutrition in the paediatric ICU: a preplanned observational study of post-randomisation treatments in the PEPaNIC trial. Lancet Respir Med. 2017;5(6):475–83.
Article
PubMed
Google Scholar
Venkatesan N, et al. Dexamethasone-induced impairment in skeletal muscle glucose transport is not reversed by inhibition of free fatty acid oxidation. Metabolism. 1996;45(1):92–100.
Article
CAS
PubMed
Google Scholar
New AM, et al. Continuous renal replacement therapy: a potential source of calories in the critically ill. Am J Clin Nutr. 2017;105(6):1559–63.
CAS
PubMed
Google Scholar
Stevenson JM, et al. In vitro glucose kinetics during continuous renal replacement therapy: implications for caloric balance in critically ill patients. Int J Artif Organs. 2013;36(12):861–8.
Article
PubMed
Google Scholar